Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Details)

v3.19.2
Net Loss per Common Share (Details) - shares
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 18,366,671 17,748,353
Warrants to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 874,189 894,189
Opus warrants to purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,880,000 1,880,000
Employee Stock Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,148,347 1,085,502
Convertible preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,000,000 1,000,000
Unvested Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 12,623,290 11,023,682
Unvested Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 840,845 1,864,980